Sotatercept trials for Pulmonary Arterial Hypertension

All Sotatercept trials · All Pulmonary Arterial Hypertension trials

Phase breakdown

Recruiting trials studying Sotatercept for Pulmonary Arterial Hypertension

• A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
  NCT07218029 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 135 locations
• A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032)
  NCT07646860 · Phase: Phase 2 · Ages: 1 Year to 17 Years · Sex: All (male and female) · 3 locations
• Right Ventricular Compensation With Sotatercept: A Prospective Single Arm Open Label Phase 4 Study to Evaluate the Effects of Sotatercept on Right Ventricular Function in Pulmonary Arterial Hypertension (RECOMPENSE)
  NCT06658522 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
  NCT05587712 · Phase: Phase 2 · Ages: 1 Year to 17 Years · Sex: All (male and female) · 35 locations

Common questions

How many trials study Sotatercept for Pulmonary Arterial Hypertension?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.